Accredited cervical smear testing service to be provided in Ireland

13/07/2011

Accredited cervical smear testing service to be provided in Ireland

Biomnis Ireland and Western Health and Social Care Trust sign agreement

Biomnis Ireland, the largest private provider of medical testing and specialised medical pathology in the country

and the Western Health and Social Care Trust in Northern Ireland have signed a two-year agreement to provide an accredited and sustainable cervical smear testing service on the island of Ireland.  This innovative collaboration between public and private sectors represents a significant development in the Irish pathology sector, particularly in the provision of indigenous cytology services.

 

 

 

The combined resources of both organisations will raise the operational capacity of cervical smear testing services in Ireland by over 40,000 tests per annum. This increase in capacity would allow Biomnis Ireland and the Western Trust to carry out a significant proportion of the Republic of Ireland’s annual caseload of cervical smear tests.  

 

“This development bodes very well for the country as a whole and its capacity to deliver a fully accredited and domestically-based cytology service,” said John O’Sullivan, Managing Director, Biomnis Ireland. “We are excited about the potential to perform more cervical screening tests in Ireland.  There is a stream of home-grown graduates that we hope will benefit from this development and we are confident that by carrying out more tests in Ireland, this will streamline the screening process further.Biomnis

 

“We are committed to investing further in the Irish market and this agreement with the Western Health and Social Care Trust in Northern Ireland is an important step in our ongoing journey as a company,” added Mr. O’Sullivan.

 

Dr Michael McKenna, Clinical Lead for Pathology Services, Western Trust, said: “The cytology department in the Western Trust has, through a series of innovative developments, streamlined its service creating capability and capacity which has enabled it to enter into this agreement with Biomnis Ireland. Through this initiative the Trust’s cytology services are continuing a tradition of cross-border working as previously Altnagelvin Hospital provided a service for the former North-Western Health Board in the Republic.  We are confident that this joint venture will support the Western Trust in innovating and continually improving the quality of its cytology services.”

 

The new cytology agreement is the latest in a series of important developments in the pathology sector on the part of Biomnis Ireland.  Last November the Biomnis Group announced a €3 million investment in the Irish sector, which involved the acquisition of Euromedic Lablink Ltd, a company formerly owned by Euromedic B.V. The investment has also led to a major test repatriation scheme to Ireland which has seen many test processes transferred from Biomnis labs in France to the Irish laboratory base at Sandyford in Dublin.  Biomnis Ireland is now the largest workplace health screening provider in Ireland.

 

The new contractual cytology agreement is for an initial two-year period, with scope to extend beyond 2013.